Search research articles
Contact Us
Filters
Showing results (31-40 of 123) with videos related to
Page
of 13
Sort By:
Allergy
|
July 30, 2016
Crossing the threshold: can outcome data from food challenges be used to predict risk of anaphylaxis in the community?
P J Turner, B K Wainstein
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 10, 2003
The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000
P J Turner, J M Greenhalgh,
The Journal of Antimicrobial Chemotherapy
|
October 24, 1997
Activity of meropenem against Enterococcus faecalis
P J Turner, J R Edwards
British Dental Journal
|
September 25, 1993
Training hygienists for an auxiliary role in orthodontics
P J Turner, R R Pinson
Allergy
|
June 21, 2016
Precautionary allergen labelling: NO MORE TRACES!
P J Turner, M H Gowland
Scandinavian Journal of Infectious Diseases. Supplementum
|
January 1, 1995
Laboratory data which differentiate meropenem and imipenem
J R Edwards, P J Turner
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
November 25, 2014
A food allergy syndrome by any other name?
P J Turner, D E Campbell
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
August 1, 1988
Worldwide assessment of the activity of cefotetan against clinical isolates
P J Turner, J R Edwards
Vaccine
|
December 22, 2015
Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease
Philip S Watson, David P J Turner
Journal of Clinical Pathology
|
May 22, 2007
Fatal case of sepsis caused by a non-haemolytic strain of Streptococcus pyogenes
David P J Turner, Sarah L Gunn
Page
of 13
Search research articles
Search
Showing results (31-40 of 123) with videos related to
Sort By:
Page
of 13
Allergy
|
July 30, 2016
Crossing the threshold: can outcome data from food challenges be used to predict risk of anaphylaxis in the community?
P J Turner, B K Wainstein
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 10, 2003
The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000
P J Turner, J M Greenhalgh,
The Journal of Antimicrobial Chemotherapy
|
October 24, 1997
Activity of meropenem against Enterococcus faecalis
P J Turner, J R Edwards
British Dental Journal
|
September 25, 1993
Training hygienists for an auxiliary role in orthodontics
P J Turner, R R Pinson
Allergy
|
June 21, 2016
Precautionary allergen labelling: NO MORE TRACES!
P J Turner, M H Gowland
Scandinavian Journal of Infectious Diseases. Supplementum
|
January 1, 1995
Laboratory data which differentiate meropenem and imipenem
J R Edwards, P J Turner
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
November 25, 2014
A food allergy syndrome by any other name?
P J Turner, D E Campbell
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
August 1, 1988
Worldwide assessment of the activity of cefotetan against clinical isolates
P J Turner, J R Edwards
Vaccine
|
December 22, 2015
Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease
Philip S Watson, David P J Turner
Journal of Clinical Pathology
|
May 22, 2007
Fatal case of sepsis caused by a non-haemolytic strain of Streptococcus pyogenes
David P J Turner, Sarah L Gunn
Page
of 13